Bipolar Patients Need Highly Targeted Treatments

This just in from the annual meeting of the American Psychiatric Association.

Regardless of the type of psychotropic medication used to treat patients with bipolar disorder, outcomes are about the same at 1 year, a retrospective chart review from the University of Toledo (lead author Dr. Ronald A. McGinnis) suggests.

For coauthor Dr. Daniel J. Rapport of the department of psychiatry at the university, the take-home message is not that medication choice is irrelevant. On the contrary, he thinks the study suggests that clinicians have to work extra hard to find drugs that work in a given patient.

Read the full article here.

No Comments

Leave a Reply

Abilify in Court – July 2017 Update

It’s been five years since I wrote, Success! I’ve Quit Abilify.  Since then, the post has received over 3500 views.  And all told, views for posts (linked below) related to the BS I endured while taking Abilify total over 49,000. The struggle is real. I haven’t posted for over a …

Polypharmacy and Bipolar Disorder

How many meds do you use to treat your bipolar disorder?  And your co-morbid afflictions?  Personally, I get off easy and take only four. In the treatment of bipolar disorder, polypharmacy (the use of multiple meds to treat a disease or disorder) is the norm.  And generally, bipolar I patients …

Heritable bipolar phenotypes pinned down

(I don’t usually quote an entire article, but this subject is near and dear to my heart….) Heritable bipolar phenotypes p inned down Published on February 14, 2014 at 5:12 PM By Eleanor McDermid, Senior medwireNews Reporter   A large study has pinpointed brain and behavioural traits that are genetically influenced and …

error: Content is protected !!